Jonas Banefelt

483 total citations
22 papers, 335 citations indexed

About

Jonas Banefelt is a scholar working on Surgery, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jonas Banefelt has authored 22 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Economics and Econometrics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jonas Banefelt's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Blood Pressure and Hypertension Studies (5 papers) and Bone health and osteoporosis research (5 papers). Jonas Banefelt is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Blood Pressure and Hypertension Studies (5 papers) and Bone health and osteoporosis research (5 papers). Jonas Banefelt collaborates with scholars based in Sweden, United States and Belgium. Jonas Banefelt's co-authors include Anna Spångéus, Kristina Åkesson, Cesar Libanati, Gustaf Ortsäter, O. Ström, Östen Ljunggren, Ervin Tóth, Linda Karlsson, Kathleen M. Fox and Emese Tóth and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Jonas Banefelt

21 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonas Banefelt Sweden	9	195	183	54	49	47	22	335
Pamela Morin United States	8	88 0.5×	110 0.6×	44 0.8×	30 0.6×	19 0.4×	13	257
AK Oglesby United States	3	296 1.5×	321 1.8×	28 0.5×	44 0.9×	70 1.5×	11	455
Merih Sarıdoğan Türkiye	5	108 0.6×	150 0.8×	17 0.3×	23 0.5×	22 0.5×	15	290
Gustaf Ortsäter Sweden	9	132 0.7×	179 1.0×	23 0.4×	40 0.8×	8 0.2×	18	293
Raffaella Michieli Italy	5	86 0.4×	156 0.9×	13 0.2×	51 1.0×	30 0.6×	13	331
Carlo Tringale United States	4	185 0.9×	307 1.7×	43 0.8×	36 0.7×	25 0.5×	5	498
Jung-Fu Chen Taiwan	6	174 0.9×	161 0.9×	9 0.2×	62 1.3×	29 0.6×	8	264
Hyun-Koo Yoon South Korea	5	236 1.2×	224 1.2×	8 0.1×	45 0.9×	47 1.0×	5	389
Di Valentine United States	4	130 0.7×	307 1.7×	19 0.4×	38 0.8×	17 0.4×	4	427
Shanette G. Daigle United States	8	245 1.3×	327 1.8×	9 0.2×	62 1.3×	14 0.3×	11	499

Countries citing papers authored by Jonas Banefelt

Since Specialization

Citations

This map shows the geographic impact of Jonas Banefelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Banefelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Banefelt more than expected).

Fields of papers citing papers by Jonas Banefelt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Banefelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Banefelt. The network helps show where Jonas Banefelt may publish in the future.

Co-authorship network of co-authors of Jonas Banefelt

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Banefelt. A scholar is included among the top collaborators of Jonas Banefelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Banefelt. Jonas Banefelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Banefelt, Jonas, et al.. (2025). Long-term cardiovascular safety of ustekinumab in psoriasis and psoriatic arthritis: Results from an observational postauthorization safety study based on Swedish national registers. Journal of the American Academy of Dermatology. 93(1). 104–114.

Lindblad, Anders, et al.. (2024). Clinical, economic, and societal burden of cystic fibrosis and the impact of the CFTR modulator, lumacaftor/ivacaftor: an assessment using linked registry data in Sweden. Journal of Medical Economics. 27(1). 897–906. 3 indexed citations

Banefelt, Jonas, et al.. (2024). Postoperative atrial fibrillation is associated with long-term morbidity and mortality in older adults: Analysis from the SWEDEHEART Registry. JTCVS Open. 19. 116–130. 5 indexed citations

Molden, Tor, et al.. (2023). Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination—A longitudinal study over 10 years based on public surveillance data in the Nordics. PLoS ONE. 18(6). e0287378–e0287378. 8 indexed citations

Svensson, Maria, F Vilela, Margrét Leósdóttir, et al.. (2022). Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study. Upsala Journal of Medical Sciences. 127. 6 indexed citations

Ström, O., Anna Spångéus, Kristina Åkesson, et al.. (2020). Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Bone. 134. 115286–115286. 52 indexed citations

Banefelt, Jonas, Gustaf Ortsäter, Alireza Moayyeri, et al.. (2020). Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting. Journal of Bone and Mineral Research. 37(1). 52–58. 9 indexed citations

Tóth, Emese, Jonas Banefelt, Kristina Åkesson, et al.. (2020). History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55 to 90 Years Presenting With a Fragility Fracture. Journal of Bone and Mineral Research. 35(5). 861–868. 50 indexed citations

Banefelt, Jonas, Kristina Åkesson, Anna Spångéus, et al.. (2019). Risk of imminent fracture following a previous fracture in a Swedish database study. Osteoporosis International. 30(3). 601–609. 92 indexed citations

10.

Lindh, Maria, Jonas Banefelt, Kathleen M. Fox, et al.. (2019). Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data. European Heart Journal - Quality of Care and Clinical Outcomes. 5(3). 225–232. 32 indexed citations

11.

Lindh, Maria, et al.. (2018). RECURRENT CARDIOVASCULAR EVENT RATES IN HIGH-RISK ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS: ESTIMATES FROM SWEDISH POPULATION-BASED REGISTER DATA. Journal of the American College of Cardiology. 71(11). A1863–A1863. 1 indexed citations

12.

Banefelt, Jonas, Kristina Åkesson, Östen Ljunggren, et al.. (2017). Short-Term Fracture (Fx) Incidence And Risk Factors Following Fracture In A Swedish Database Study. Osteoporosis International. 28. 1 indexed citations

13.

Spångéus, Anna, Kristina Åkesson, Östen Ljunggren, et al.. (2017). OP0050 The treatment gap after fracture in osteoporosis patients in sweden. Annals of the Rheumatic Diseases. 76. 72–72. 5 indexed citations

14.

Banefelt, Jonas, et al.. (2016). Lipid‐lowering treatment patterns in patients with new cardiovascular events – estimates from population‐based register data in Sweden. International Journal of Clinical Practice. 70(3). 222–228. 1 indexed citations

15.

Banefelt, Jonas, Kathleen M. Fox, Johan Mesterton, et al.. (2015). Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. The European Journal of Health Economics. 17(9). 1117–1124. 25 indexed citations

16.

Fox, Kathleen M., Johan Mesterton, Jonas Banefelt, et al.. (2015). Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data. The European Journal of Health Economics. 17(5). 591–601. 22 indexed citations

17.

Banefelt, Jonas, Kathleen M. Fox, Johan Mesterton, et al.. (2014). Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden. Value in Health. 17(7). A327–A328. 1 indexed citations

18.

Banefelt, Jonas, Alexander Liede, Johan Mesterton, et al.. (2014). Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden. Cancer Epidemiology. 38(4). 442–447. 8 indexed citations

19.

Banefelt, Jonas, Johan Mesterton, Kathleen M. Fox, et al.. (2014). Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden. Value in Health. 17(7). A492–A492. 1 indexed citations

20.

Hernandez, Rohini K., Johan Mesterton, Jonas Banefelt, et al.. (2013). Predictors of clinical metastases and survival among nonmetastatic prostate cancer (PC) patients (pts) treated with androgen-deprivation therapy (ADT) in Sweden.. Journal of Clinical Oncology. 31(15_suppl). e16066–e16066. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact